表紙
市場調查報告書

正子放出斷層攝影(PET)系統:醫療設備的開發平台評估

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 952799
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
正子放出斷層攝影(PET)系統:醫療設備的開發平台評估 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年08月01日內容資訊: 英文 62 Pages
簡介

正子輻射斷層攝影(PET)系統掃描,是有助於揭示組織和內臟器官的功能的影像檢查。 PET掃描,使用放射性藥物(示踪劑)表現該活動。按照PET掃描檢查的內臟器官以及組織,注射,吞嚥或吸入示踪劑。

本報告提供正子放出斷層攝影(PET)系統的開發中產品調查分析,以各開發階段比較分析為焦點,提供包含開發中管道產品的主要企業,進行中的臨床試驗相關之系統性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 各開發階段的開發中產品
  • 各地區的開發中產品
  • 各法規途徑的開發中產品
  • 各核准預定日的開發中產品
  • 進行中的臨床試驗

第4章 企業開發中的開發中產品

  • 正子輻射斷層攝影(PET)系統的企業-各開發階段的開發中產品
  • 各開發階段的開發中產品

第5章 企業與產品概要

  • Brain Biosciences Inc
  • General De Equipment for Medical Imaging SA
  • Jagiellonian University
  • Lightpoint Medical Ltd
  • Nuclear, Plasma, and Radiological Engineering
  • Philips Healthcare
  • Positrigo AG
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • University of Washington
  • West Virginia University

第6章 最新趨勢

第7章 附錄

目錄
Product Code: GDME0947EPD

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Positron Emission Tomography (PET) Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Positron Emission Tomography (PET) Systems scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity. The tracer may be injected, swallowed or inhaled, depending on which organ or tissue is being studied by the PET scan.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

2 Introduction

3 Products under Development

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • 3.5 Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development

5 Positron Emission Tomography (PET) Systems Companies and Product Overview

  • 5.1 Brain Biosciences Inc Company Overview
  • 5.2 General De Equipment for Medical Imaging SA Company Overview
  • 5.3 Jagiellonian University Company Overview
  • 5.4 Lightpoint Medical Ltd Company Overview
  • 5.5 Nuclear, Plasma, and Radiological Engineering Company Overview
  • 5.6 Philips Healthcare Company Overview
  • 5.7 Positrigo AG Company Overview
  • 5.8 Ray Vision Intl Corp. Company Overview
  • 5.9 Stanford University Company Overview
  • 5.10 SynchroPET Company Overview
  • 5.11 University of Washington Company Overview
  • 5.12 West Virginia University Company Overview

6 Positron Emission Tomography (PET) Systems- Recent Developments

7 Appendix

List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Table 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials
  • Table 6: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • Table 7: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 8: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Figure 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials